Cure Alzheimer's Fund Cure Alzheimer's Fund

Carlos Cruchaga, Ph.D.

Professor of Psychiatry, Washington University School of Medicine in St. Louis; Director, NeuroGenomics and Informatics Center, Washington School of Medicine in St. Louis

Carlos Cruchaga, Ph.D., is a human genomicist with expertise in multiomics, informatics, and neurodegeneration. He completed his Ph.D. in Biochemistry and Molecular Biology in 2005 at the University of Navarra in Spain. During his first post-doctoral, he conducted statistical human genetics studies focused on Alzheimer’s and Parkinson’s disease, completing his training in quantitative human genomics. Dr. Cruchaga established his laboratory at Washington University in 2011, studying the genetic architecture of neurodegenerative diseases. His interests are focused on using human genomic and other omic data (proteomics, metabolomics, lipidomics) to identify and understand the biological processes that lead to Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, and other neurodegenerative processes. In 2019, he became the leader of the NeuroGenomics and Informatics group at Washington University.

Visit the Cruchaga Lab website.

Visit the NeuroGenomics and Informatics Center website.

Follow Dr. Cruchaga on X (formerly known as Twitter): @ccrugom

Follow the NeuroGenomics and Informatics Center on X (formerly known as Twitter): @ Neuro_Genomics

Related Research:

Multiomic and Functional Characterization of sTREM2 Modifiers Carlos Cruchaga 2024-02-28

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.

Project Description Researchers Funding
Multiomic and Functional Characterization of sTREM2 Modifiers 2024

$200,356

Selected Publications

These published papers resulted from Cure Alzheimer’s Fund support.

Delvenne, A., Gobom, J., Schindler, S. E., Kate, M. T., Reus, L. M., Dobricic, V., Tijms, B. M., Benzinger, T. L. S., Cruchaga, C., ... Bertram, L., … Zetterberg, H., ... Vos, S. J. B. CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer’s disease, Alzheimer's & Dementia, July 6, 2024, Read More

Xiong, C., Luo, J., Wolk, D. A., Shaw, L. M., Roberson, E. D., Murchison, C. F., Henson, R. L., Benzinger, T. L. S., Bui, Q., Agboola, F., Grant, E., Gremminger, E. N., Moulder, K. L., Geldmacher, D. S., Clay, O. J., Babulal, G., Cruchaga, C., Holtzman, D. M., Bateman, R. J., Morris, J. C., Schindler, S. E. Baseline levels and longitudinal changes in plasma Aβ42/40 among Black and white individuals, Nature Communications, July 2, 2024, Read More

Back to Our Researchers